Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junyi Li

Showing results (421-430 of 423) with videos related to

Pageof 43
Sort By:
You have reached the last page of results.This site can display upto 423 results.
Hepatology International|June 5, 2023
Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C studyYu Jun Wong, Sally Tran, Chung-Feng Huang, et al.
The American Journal of Gastroenterology|June 14, 2026
Higher incidence of hepatocellular carcinoma in suppressed hepatitis B cirrhosis compared to cured hepatitis C cirrhosisJiyoon Park, Sally Tran, Eiichi Ogawa, et al.
Journal of Clinical and Translational Hepatology|July 12, 2024
Real-world Effectiveness and Tolerability of Interferon-free Direct-acting Antiviral for 15,849 Patients with Chronic Hepatitis C: A Multinational Cohort StudyFanpu Ji, Sally Tran, Eiichi Ogawa, et al.
Pageof 43

Showing results (421-430 of 423) with videos related to

Sort By:
Pageof 43
You have reached the last page of results.This site can display upto 423 results.
Hepatology International|June 5, 2023
Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C studyYu Jun Wong, Sally Tran, Chung-Feng Huang, et al.
The American Journal of Gastroenterology|June 14, 2026
Higher incidence of hepatocellular carcinoma in suppressed hepatitis B cirrhosis compared to cured hepatitis C cirrhosisJiyoon Park, Sally Tran, Eiichi Ogawa, et al.
Journal of Clinical and Translational Hepatology|July 12, 2024
Real-world Effectiveness and Tolerability of Interferon-free Direct-acting Antiviral for 15,849 Patients with Chronic Hepatitis C: A Multinational Cohort StudyFanpu Ji, Sally Tran, Eiichi Ogawa, et al.
Pageof 43